Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer
- PMID: 12448047
Item in Clipboard
Long-term use of estrogen-only hormone replacement therapy (HRT) linked with increased risk of ovarian cancer
Ginecol Obstet Mex.
2002 Aug.
No abstract available
Similar articles
-
[Estrogen replacement therapy and breast cancer].Tidsskr Nor Laegeforen. 2005 Feb 3;125(3):282-5. Tidsskr Nor Laegeforen. 2005. PMID: 15702147 Norwegian.
-
Estrogen replacement therapy and ovarian cancer.Epidemiology. 2004 Jan;15(1):100-4. doi: 10.1097/01.ede.0000091606.31903.8e. Epidemiology. 2004. PMID: 14712153
-
Menopausal hormones and risk of ovarian cancer.Am J Obstet Gynecol. 2005 Jul;193(1):76-82. doi: 10.1016/j.ajog.2004.11.013. Am J Obstet Gynecol. 2005. PMID: 16021062
-
[Hormone therapies and ovarian cancer].Duodecim. 2002;118(4):349-56. Duodecim. 2002. PMID: 12233039 Review. Finnish. No abstract available.
-
Estrogen-progestogen replacement therapy and ovarian cancer: an update.Eur J Cancer Prev. 2006 Dec;15(6):490-2. doi: 10.1097/01.cej.0000205026.14515.de. Eur J Cancer Prev. 2006. PMID: 17106327 Review.
Cited by
-
Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma.Front Pharmacol. 2024 Jun 20;15:1433540. doi: 10.3389/fphar.2024.1433540. eCollection 2024. Front Pharmacol. 2024. PMID: 38966543 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical